• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Immunohistochemical detection of p53, PTEN, Rb, and p16 in canine osteosarcoma using tissue microarray.利用组织芯片对犬骨肉瘤中p53、PTEN、Rb和p16进行免疫组织化学检测。
J Vet Diagn Invest. 2018 Jul;30(4):504-509. doi: 10.1177/1040638718770239. Epub 2018 Apr 9.
2
Expression and significance of p53, rb, p21/waf-1, p16/ink-4a, and PTEN tumor suppressors in canine melanoma.p53、rb、p21/waf-1、p16/ink-4a和PTEN肿瘤抑制因子在犬黑色素瘤中的表达及意义
Vet Pathol. 2002 Jul;39(4):458-72. doi: 10.1354/vp.39-4-458.
3
Tumor suppressor PTEN is mutated in canine osteosarcoma cell lines and tumors.肿瘤抑制因子PTEN在犬骨肉瘤细胞系和肿瘤中发生突变。
Vet Pathol. 2002 May;39(3):372-8. doi: 10.1354/vp.39-3-372.
4
Inactivation of p53 and retinoblastoma family pathways in canine osteosarcoma cell lines.犬骨肉瘤细胞系中p53和视网膜母细胞瘤家族通路的失活
Vet Pathol. 2000 Jan;37(1):54-61. doi: 10.1354/vp.37-1-54.
5
The significance of p53 and retinoblastoma pathways in canine hemangiosarcoma.p53和视网膜母细胞瘤通路在犬血管肉瘤中的意义。
J Vet Med Sci. 2007 Mar;69(3):271-8. doi: 10.1292/jvms.69.271.
6
The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.局部晚期膀胱癌中p16INK4a、视网膜母细胞瘤和p53免疫反应性的患病率及临床病理相关性
Urol Oncol. 2004 Mar-Apr;22(2):112-8. doi: 10.1016/S1078-1439(03)00176-5.
7
Status of the p53, Rb and MDM2 genes in canine osteosarcoma.犬骨肉瘤中p53、Rb和MDM2基因的状态
Anticancer Res. 1998 Nov-Dec;18(6A):4449-53.
8
Canine gastric carcinoma: immunohistochemical expression of cell cycle proteins (p53, p21, and p16) and heat shock proteins (Hsp27 and Hsp70).犬胃腺癌:细胞周期蛋白(p53、p21 和 p16)和热休克蛋白(Hsp27 和 Hsp70)的免疫组织化学表达。
Vet Pathol. 2011 Jan;48(1):322-9. doi: 10.1177/0300985810375050. Epub 2010 Jun 29.
9
Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.存档人类实体瘤中细胞周期蛋白依赖性激酶抑制剂2/多重肿瘤抑制基因1(CDKN2/MTS1)产物p16INK4A的免疫组织化学检测:与视网膜母细胞瘤蛋白表达的相关性
Cancer Res. 1995 Dec 15;55(24):6006-11.
10
Immunohistochemical investigation of cell cycle and apoptosis regulators (survivin, β-catenin, p53, caspase 3) in canine appendicular osteosarcoma.犬附肢骨肉瘤中细胞周期和凋亡调控因子(存活素、β-连环蛋白、p53、半胱氨酸蛋白酶 3)的免疫组织化学研究。
BMC Vet Res. 2012 Jun 11;8:78. doi: 10.1186/1746-6148-8-78.

引用本文的文献

1
Predictive value of RNAscope hybridization and p53 immunohistochemistry for mutational status in canine diffuse large B-cell lymphoma.RNAscope杂交和p53免疫组织化学对犬弥漫性大B细胞淋巴瘤突变状态的预测价值
Vet Q. 2024 Dec;44(1):1-9. doi: 10.1080/01652176.2024.2403453. Epub 2024 Sep 16.
2
Immunohistochemical Expression of PTEN in Canine Gliomas.PTEN在犬神经胶质瘤中的免疫组化表达
Animals (Basel). 2024 Jul 20;14(14):2115. doi: 10.3390/ani14142115.
3
Establishment and Characterization of Cell Lines from Canine Metastatic Osteosarcoma.建立和鉴定犬转移性骨肉瘤细胞系。
Cells. 2023 Dec 21;13(1):25. doi: 10.3390/cells13010025.
4
Isolation and Characterization of Novel Canine Osteosarcoma Cell Lines from Chemotherapy-Naïve Patients.从化疗初治患者中分离和鉴定新型犬骨肉瘤细胞系。
Cells. 2023 Mar 27;12(7):1026. doi: 10.3390/cells12071026.
5
Validation of p53 Immunohistochemistry (PAb240 Clone) in Canine Tumors with Next-Generation Sequencing (NGS) Analysis.利用下一代测序(NGS)分析验证犬类肿瘤中p53免疫组织化学(PAb240克隆)
Animals (Basel). 2023 Mar 1;13(5):899. doi: 10.3390/ani13050899.
6
Clinicopathological assessment of cancer/testis antigens NY‑ESO‑1 and MAGE‑A4 in osteosarcoma.骨肉瘤中肿瘤/睾丸抗原 NY-ESO-1 和 MAGE-A4 的临床病理评估。
Eur J Histochem. 2022 Jun 23;66(3):3377. doi: 10.4081/ejh.2022.3377.
7
DNA damage response proteins in canine cancer as potential research targets in comparative oncology.犬科癌症中的 DNA 损伤反应蛋白作为比较肿瘤学中的潜在研究靶点。
Vet Comp Oncol. 2022 Jun;20(2):347-361. doi: 10.1111/vco.12795. Epub 2022 Jan 10.
8
Recent Advances in the Discovery of Biomarkers for Canine Osteosarcoma.犬骨肉瘤生物标志物发现的最新进展
Front Vet Sci. 2021 Oct 1;8:734965. doi: 10.3389/fvets.2021.734965. eCollection 2021.
9
An Immunohistochemical Study of the PTEN/AKT Pathway Involvement in Canine and Feline Mammary Tumors.PTEN/AKT信号通路参与犬猫乳腺肿瘤的免疫组织化学研究
Animals (Basel). 2021 Feb 1;11(2):365. doi: 10.3390/ani11020365.
10
Characterization of D-17 Canine Osteosarcoma Cell Line and Evaluation of Its Ability to Response to Infective Stressor Used as Alternative Anticancer Therapy.D-17犬骨肉瘤细胞系的特性及其对用作替代抗癌疗法的感染应激源的反应能力评估。
Animals (Basel). 2020 Oct 28;10(11):1981. doi: 10.3390/ani10111981.

本文引用的文献

1
A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis.一项“睡美人”正向遗传学筛选鉴定出驱动骨肉瘤发生和转移的新基因及信号通路。
Nat Genet. 2015 Jun;47(6):615-24. doi: 10.1038/ng.3293. Epub 2015 May 11.
2
Translational biology of osteosarcoma.骨肉瘤的转化生物学。
Nat Rev Cancer. 2014 Nov;14(11):722-35. doi: 10.1038/nrc3838. Epub 2014 Oct 16.
3
Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.犬骨肉瘤:一种用于为儿科肿瘤学提供信息的自然发生的疾病。
ILAR J. 2014;55(1):69-85. doi: 10.1093/ilar/ilu009.
4
Genome-wide analyses implicate 33 loci in heritable dog osteosarcoma, including regulatory variants near CDKN2A/B.全基因组分析表明,33个基因座与犬遗传性骨肉瘤有关,包括CDKN2A/B附近的调控变异。
Genome Biol. 2013 Dec 12;14(12):R132. doi: 10.1186/gb-2013-14-12-r132.
5
p53 mutations in cancer.癌症中的 p53 突变。
Nat Cell Biol. 2013 Jan;15(1):2-8. doi: 10.1038/ncb2641.
6
Immunohistochemical investigation of cell cycle and apoptosis regulators (survivin, β-catenin, p53, caspase 3) in canine appendicular osteosarcoma.犬附肢骨肉瘤中细胞周期和凋亡调控因子(存活素、β-连环蛋白、p53、半胱氨酸蛋白酶 3)的免疫组织化学研究。
BMC Vet Res. 2012 Jun 11;8:78. doi: 10.1186/1746-6148-8-78.
7
Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.应用 array-CGH 和 RT-qPCR 对犬骨肉瘤进行特征分析:犬骨肉瘤的基因组失衡特征与人骨肉瘤相似。
Genes Chromosomes Cancer. 2011 Nov;50(11):859-74. doi: 10.1002/gcc.20908. Epub 2011 Aug 11.
8
Dog models of naturally occurring cancer.自然发生癌症的犬模型。
Trends Mol Med. 2011 Jul;17(7):380-8. doi: 10.1016/j.molmed.2011.02.004. Epub 2011 Mar 24.
9
A role for the retinoblastoma protein as a regulator of mouse osteoblast cell adhesion: implications for osteogenesis and osteosarcoma formation.视网膜母细胞瘤蛋白作为调节小鼠成骨细胞黏附的作用:对成骨和骨肉瘤形成的影响。
PLoS One. 2010 Nov 11;5(11):e13954. doi: 10.1371/journal.pone.0013954.
10
Influence of different decalcifying agents on EGF and EGFR immunostaining.不同脱钙剂对 EGF 和 EGFR 免疫染色的影响。
Acta Histochem. 2011 Jul;113(4):484-8. doi: 10.1016/j.acthis.2010.04.006. Epub 2010 Jul 3.

利用组织芯片对犬骨肉瘤中p53、PTEN、Rb和p16进行免疫组织化学检测。

Immunohistochemical detection of p53, PTEN, Rb, and p16 in canine osteosarcoma using tissue microarray.

作者信息

Russell Duncan S, Jaworski Lauren, Kisseberth William C

机构信息

Department of Biomedical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, OR (Russell).

Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH (Jaworski, Kisseberth).

出版信息

J Vet Diagn Invest. 2018 Jul;30(4):504-509. doi: 10.1177/1040638718770239. Epub 2018 Apr 9.

DOI:10.1177/1040638718770239
PMID:29629647
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6505918/
Abstract

Although inactivating mutations of tumor suppressor genes are well described in cell lines of canine osteosarcoma (OS), expression of tumor suppressor proteins in spontaneous disease is poorly characterized. We determined the immunohistochemical expression of p53, PTEN, Rb, and p16 in a large cohort of dogs with OS. Formalin-fixed, paraffin-embedded samples of canine OS were analyzed retrospectively. Primary tumor samples from 145 dogs, collected between 2003 and 2008, were evaluated by tissue microarray. Streptavidin-biotin complex immunohistochemistry was performed using monoclonal antibodies for Rb and PTEN and polyclonal antibodies for p16 and p53. The average age of dogs was 7.6 y, and 118 of 145 (81%) were purebred. Most commonly represented purebreds were Greyhound (23%), Rottweiler (11%), and Labrador Retriever (10%). Immunohistochemical detection of p53, PTEN, Rb, and p16 was 81%, 61%, 66%, and 66%, respectively. The staining pattern for p16 was primarily cytoplasmic; the predominant pattern for PTEN, Rb, and p53 was cytoplasmic and nuclear. Exclusively cytoplasmic staining was noted in 19% of samples positive for p53 and 8% of samples positive for Rb. Kaplan-Meier curves showed that protein expression was not associated with significant differences in overall survival ( p > 0.191). We documented heterogeneity in both immunostaining and subcellular localization of tumor suppressor proteins, providing further characterization of canine OS.

摘要

虽然肿瘤抑制基因的失活突变在犬骨肉瘤(OS)细胞系中已有充分描述,但在自发性疾病中肿瘤抑制蛋白的表达情况却鲜为人知。我们测定了一大群患骨肉瘤犬中p53、PTEN、Rb和p16的免疫组化表达。对福尔马林固定、石蜡包埋的犬骨肉瘤样本进行回顾性分析。通过组织芯片对2003年至2008年间收集的145只犬的原发性肿瘤样本进行评估。使用抗Rb和PTEN的单克隆抗体以及抗p16和p53的多克隆抗体进行链霉亲和素-生物素复合物免疫组化。犬的平均年龄为7.6岁,145只中有118只(81%)为纯种犬。最常见的纯种犬是灵缇犬(23%)、罗威纳犬(11%)和拉布拉多寻回犬(10%)。p53、PTEN、Rb和p16的免疫组化检测阳性率分别为81%、61%、66%和66%。p16的染色模式主要为细胞质;PTEN、Rb和p53的主要模式为细胞质和细胞核。在19%的p53阳性样本和8%的Rb阳性样本中观察到仅细胞质染色。Kaplan-Meier曲线显示蛋白表达与总生存期的显著差异无关(p>0.191)。我们记录了肿瘤抑制蛋白免疫染色和亚细胞定位的异质性,为犬骨肉瘤提供了进一步的特征描述。